BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Epidermal growth factor receptor 2 (HER2; EGFR2; ErbB2; neu); valosin containing protein (VCP; p97)

June 11, 2015 7:00 AM UTC

Computational and in vitro studies suggest inhibiting ER-associated degradation (ERAD) could help treat HER2-positive breast cancer. In silico genomic and transcriptomic analyses of primary breast tum...